On July 8, 2010
Senate Probe Might Want to Ask Why Drug Companies Invite Lawsuits By Punishing Whistleblowers
Sen. Chuck Grassley’s inquiry into the whistleblower policies at 16 pharmaceutical companies — Pfizer (PFE), AstraZeneca (AZN), and Novartis (NVS) among them — will likely be a fertile one if he pursues it beyond the companies’ response letters: In a
…
0 Comments